{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:18:25Z","timestamp":1792167505476,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bbrc.2021.04.066","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T12:06:32Z","timestamp":1619438792000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity"],"prefix":"10.1016","volume":"558","author":[{"given":"Lingyan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiannan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1475-5183","authenticated-orcid":false,"given":"Qiangsun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.04.066_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week","volume":"73","author":"Davidson","year":"2019","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(02)02051-X","article-title":"Relationship between obesity, insulin resistance, and coronary heart disease risk","volume":"40","author":"Abbasi","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2009.03.002","article-title":"The impairment of preconditioning-mediated cardioprotection in pathological conditions","volume":"60","author":"Balakumar","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2021.04.066_bib4","doi-asserted-by":"crossref","first-page":"R920","DOI":"10.1152\/ajpregu.00520.2006","article-title":"Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance","volume":"292","author":"Katakam","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib5","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s00125-004-1514-4","article-title":"Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes","volume":"47","author":"Kristiansen","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2021.04.066_bib6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1258\/ebm.2011.011165","article-title":"Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway","volume":"236","author":"Song","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbrc.2021.04.066_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13105-019-00664-w","article-title":"Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms","volume":"75","author":"Tyagi","year":"2019","journal-title":"J.\u00a0Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2021.04.066_bib8","first-page":"4126820","article-title":"Reducing caloric intake prevents ischemic injury and myocardial dysfunction and affects anesthetic cardioprotection in type 2 diabetic rats","volume":"2017","author":"van den Brom","year":"2017","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.bbrc.2021.04.066_bib9","doi-asserted-by":"crossref","first-page":"H13","DOI":"10.1152\/ajpheart.01056.2008","article-title":"Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system","volume":"296","author":"Laczy","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tibs.2010.04.005","article-title":"O-GlcNAc signaling: a metabolic link between diabetes and cancer?","volume":"35","author":"Slawson","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2021.04.066_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/physrev.00043.2019","article-title":"Role of O-linked N-acetylglucosamine protein modification in cellular (Patho)Physiology","volume":"101","author":"Chatham","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2021.04.066_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tem.2013.02.002","article-title":"Cracking the O-GlcNAc code in metabolism","volume":"24","author":"Ruan","year":"2013","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrm.2017.22","article-title":"Protein O-GlcNAcylation: emerging mechanisms and functions","volume":"18","author":"Yang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacbts.2018.01.005","article-title":"Diabetes exacerbates myocardial ischemia\/reperfusion injury by down-regulation of MicroRNA and up-regulation of O-GlcNAcylation","volume":"3","author":"Wang","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.bbrc.2021.04.066_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4093\/kdj.2010.34.4.211","article-title":"O-GlcNAc modification: friend or foe in diabetic cardiovascular disease","volume":"34","author":"Karunakaran","year":"2010","journal-title":"Korean Diabetes J."},{"key":"10.1016\/j.bbrc.2021.04.066_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14789450.2013.820536","article-title":"Protein O-GlcNAcylation in diabetes and diabetic complications","volume":"10","author":"Ma","year":"2013","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bbrc.2021.04.066_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvu132","article-title":"Effective glycaemic control critically determines insulin cardioprotection against ischaemia\/reperfusion injury in anaesthetized dogs","volume":"103","author":"Yu","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2021.04.066_bib18","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.febslet.2006.04.051","article-title":"Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1","volume":"580","author":"Gandy","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2021.04.066_bib19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.114.302968","article-title":"Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus","volume":"114","author":"Heath","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2021.04.066_bib20","article-title":"Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2021.04.066_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pharmthera.2013.04.008","article-title":"The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias","volume":"139","author":"Curtis","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2021.04.066_bib22","doi-asserted-by":"crossref","first-page":"35313","DOI":"10.1074\/jbc.M404133200","article-title":"Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels","volume":"279","author":"Marshall","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.04.066_bib23","doi-asserted-by":"crossref","first-page":"C862","DOI":"10.1152\/ajpcell.00491.2018","article-title":"Acute increases in O-GlcNAc indirectly impair mitochondrial bioenergetics through dysregulation of LonP1-mediated mitochondrial protein complex turnover","volume":"316","author":"Wright","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020404","article-title":"The role of O-GlcNAcylation for protection against ischemia-reperfusion injury","volume":"20","author":"Jensen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2021.04.066_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/BST20160164","article-title":"O-GlcNAcylation and cardiovascular disease","volume":"45","author":"Wright","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2021.04.066_bib26","doi-asserted-by":"crossref","first-page":"H2227","DOI":"10.1152\/ajpheart.01091.2006","article-title":"Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation","volume":"292","author":"Fulop","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00726-010-0728-7","article-title":"Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes","volume":"40","author":"Ngoh","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbrc.2021.04.066_bib28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/cvr\/cvq349","article-title":"Insulin says NO to cardiovascular disease","volume":"89","author":"Yu","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2021.04.066_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00642","article-title":"Chronic O-GlcNAcylation and diabetic cardiomyopathy: the bitterness of glucose","volume":"9","author":"Ducheix","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib30","doi-asserted-by":"crossref","first-page":"21411","DOI":"10.1074\/jbc.M800677200","article-title":"Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling","volume":"283","author":"Whelan","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.04.066_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nature06668","article-title":"Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance","volume":"451","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2021.04.066_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molmet.2018.02.010","article-title":"Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivity","volume":"11","author":"Shi","year":"2018","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1161\/ATVBAHA.119.312192","article-title":"Metabolic stress and cardiovascular disease in diabetes mellitus: the role of protein O-GlcNAc modification","volume":"39","author":"Chen","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2021.04.066_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease","volume":"80","author":"Hart","year":"2011","journal-title":"Annu. Rev. Biochem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21006781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21006781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:05:23Z","timestamp":1757765123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21006781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"alternative-id":["S0006291X21006781"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.066","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}